BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Diagnosis
35 results:

  • 1. Upregulation of p16INK4A in Peripheral White Blood Cells as a Novel Screening Marker for colorectal Carcinoma.
    Thin KA; Angsuwatcharakon P; Edwards SW; Mutirangura A; Puttipanyalears C
    Asian Pac J Cancer Prev; 2022 Nov; 23(11):3753-3761. PubMed ID: 36444588
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. EMS-Net: Enhanced Multi-Scale Network for Polyp Segmentation.
    Wang M; An X; Li Y; Li N; Hang W; Liu G
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():2936-2939. PubMed ID: 34891860
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank.
    De Vincentis A; Tavaglione F; Spagnuolo R; Pujia R; Tuccinardi D; Mascianà G; Picardi A; Antonelli Incalzi R; Valenti L; Romeo S; Vespasiani-Gentilucci U
    Int J Obes (Lond); 2022 Mar; 46(3):486-493. PubMed ID: 34750514
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Immune cell profiles in the tumor microenvironment of early-onset, intermediate-onset, and later-onset colorectal cancer.
    Ugai T; Väyrynen JP; Lau MC; Borowsky J; Akimoto N; Väyrynen SA; Zhao M; Zhong R; Haruki K; Dias Costa A; Fujiyoshi K; Arima K; Wu K; Chan AT; Cao Y; Song M; Fuchs CS; Wang M; Lennerz JK; Ng K; Meyerhardt JA; Giannakis M; Nowak JA; Ogino S
    Cancer Immunol Immunother; 2022 Apr; 71(4):933-942. PubMed ID: 34529108
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Applying Latent Class Analysis on cancer Registry Data to Identify and Compare Health Disparity Profiles in colorectal cancer Surgical Treatment Delay.
    Montiel Ishino FA; Odame EA; Villalobos K; Whiteside M; Mamudu H; Williams F
    J Public Health Manag Pract; 2022 Mar-Apr 01; 28(2):E487-E496. PubMed ID: 33729186
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A National Study of colorectal cancer Survivorship Disparities: A Latent Class Analysis Using SEER (Surveillance, Epidemiology, and End Results) Registries.
    Montiel Ishino FA; Odame EA; Villalobos K; Liu X; Salmeron B; Mamudu H; Williams F
    Front Public Health; 2021; 9():628022. PubMed ID: 33718323
    [No Abstract]    [Full Text] [Related]  

  • 7. American Registry of Pathology Expert Opinions: Evaluation of poorly differentiated malignant neoplasms on limited samples - Gastrointestinal mucosal biopsies.
    Bellizzi AM; Montgomery EA; Hornick JL
    Ann Diagn Pathol; 2020 Feb; 44():151419. PubMed ID: 31786484
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients.
    Ribeiro-Samy S; Oliveira MI; Pereira-Veiga T; Muinelo-Romay L; Carvalho S; Gaspar J; Freitas PP; López-López R; Costa C; Diéguez L
    Sci Rep; 2019 May; 9(1):8032. PubMed ID: 31142796
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Laparoscopic segmental resection of the rectum for upper rectal intussusception caused by a giant rectal lipoma: A case report.
    Wei R; Xu W; Xiao Y; Zeng F; Mao S
    Medicine (Baltimore); 2018 Sep; 97(39):e12272. PubMed ID: 30278497
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Understanding Comorbidity Profiles and Their Effect on Treatment and Survival in Patients With colorectal cancer.
    Hahn EE; Gould MK; Munoz-Plaza CE; Lee JS; Parry C; Shen E
    J Natl Compr Canc Netw; 2018 Jan; 16(1):23-34. PubMed ID: 29295878
    [No Abstract]    [Full Text] [Related]  

  • 11. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with colorectal cancer - Exploratory Analysis of Their Biomarker Potential.
    Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
    Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. C77G in ptprc (cd45) is no risk allele for ovarian cancer, but associated with less aggressive disease.
    Landskron J; Kraggerud SM; Wik E; Dørum A; Bjørnslett M; Melum E; Helland Ø; Bjørge L; Lothe RA; Salvesen HB; Taskén K
    PLoS One; 2017; 12(7):e0182030. PubMed ID: 28759630
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Extensive colorectal lymphomatous polyposis complicated by acute intestinal obstruction: a case report.
    Waisberg J; Anderi ADV; Cardoso PAS; Borducchi JHM; Germini DE; Franco MIF; Vasconcellos C
    J Med Case Rep; 2017 Jul; 11(1):190. PubMed ID: 28705174
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Circulating Myeloid Suppressor Cells and Their Role in Tumour Immunology].
    Pilatova K; Budinská E; Bensciková B; Nenutil R; Šefr R; Fedorová L; Hanáková B; Brychtová V; Zdražilová Dubská L
    Klin Onkol; 2017; 30(Supplementum1):166-169. PubMed ID: 28471197
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Coexisting tubular adenoma with a neuroendocrine carcinoma of colon allowing early surgical intervention and implicating a shared stem cell origin.
    Soliman ML; Tiwari A; Zhao Q
    World J Gastroenterol; 2017 Feb; 23(6):1106-1112. PubMed ID: 28246485
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Evaluation of lymph flow patterns in splenic flexural colon cancers using laparoscopic real-time indocyanine green fluorescence imaging.
    Watanabe J; Ota M; Suwa Y; Ishibe A; Masui H; Nagahori K
    Int J Colorectal Dis; 2017 Feb; 32(2):201-207. PubMed ID: 27695977
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Regular Aspirin Use Associates With Lower Risk of colorectal cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.
    Cao Y; Nishihara R; Qian ZR; Song M; Mima K; Inamura K; Nowak JA; Drew DA; Lochhead P; Nosho K; Morikawa T; Zhang X; Wu K; Wang M; Garrett WS; Giovannucci EL; Fuchs CS; Chan AT; Ogino S
    Gastroenterology; 2016 Nov; 151(5):879-892.e4. PubMed ID: 27475305
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment.
    Malara N; Trunzo V; Foresta U; Amodio N; De Vitis S; Roveda L; Fava M; Coluccio M; Macrì R; Di Vito A; Costa N; Mignogna C; Britti D; Palma E; Mollace V
    J Transl Med; 2016 May; 14(1):133. PubMed ID: 27176720
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Detection of KRAS,NRAS and BRAF gene mutations in colorectal carcinoma].
    Zhang K; Xu J; Yan L; Liu X; Xu F; Liu Y
    Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):254-7. PubMed ID: 25975908
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Methods for detecting circulating cancer stem cells (CCSCs) as a novel approach for diagnosis of colon cancer relapse/metastasis.
    Kantara C; O'Connell MR; Luthra G; Gajjar A; Sarkar S; Ullrich RL; Singh P
    Lab Invest; 2015 Jan; 95(1):100-12. PubMed ID: 25347154
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.